Molecular genetic testing for prenatal diagnosis

Clinics in Laboratory Medicine

Volumn 23, Issue 2, 2003, Pages 481-502

  Tantravahi, Umadevi ^a,b   Wheeler, Patricia ^c,d  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MARKER;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; DIAGNOSTIC ACCURACY; DNA SEQUENCE; FETUS; GENETIC ANALYSIS; HUMAN; MOLECULAR GENETICS; MUTATION; POLYMERASE CHAIN REACTION; PRADER WILLI SYNDROME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

EID: 0038786859     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(03)00035-0     Document Type: Review

References (65)

1. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, et al. Fragile X genotype characterized by an unstable region of D.N.A. Science 1991;252:1179-81.
2. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991;252:1097-102.
3. Cummings CJ, Zoghbi HY. Trinucleotide repeats: mechanisms and pathophysiology. Annu Rev Genomics Hum Genet 2000;1:281-328.
4. Chang JC, Kan YW. A sensitive test for prenatal diagnosis of sickle cell anemia: direct analysis of amniocyte DNA with Mstll. Trans Assoc Am Physicians 1982;95:71-8.
5. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-17.
6. Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA 1977;74:5350-4.
7. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-50.
8. Eisenstein BI. The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis. N Engl J Med 1990;322:178-83.
9. Erlich HA, Gelfand D, Sninsky JJ. Recent advances in the polymerase chain reaction. Science 1991;252:1643-51.
10. Maxam AM, Gilbert W. A new method for sequencing DNA, 1977. Biotechnology 1992;24:99-103,
11. Sanger F, Air GM, Barrell BG, Brown NL, Coulson AR, Fiddes CA, et al. Nucleotide sequence of bacteriophage phi X174 DNA. Nature 1977;265:687-95.
12. Hattori M, Yoshioka K, Sakaki Y. High-sensitive fluorescent DNA sequencing and its application for detection and mass-screening of point mutations. Electrophoresis 1992;13:560-5.
13. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
14. The Cystic Fibrosis Genetic Analysis Consortium. Population variation of common cystic fibrosis mutations. Hum Mutat 1994;4:167.
15. Gardner RJ. A new estimate of the achondroplasia mutation rate. Clin Genet 1977;11:31-8.
16. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999;89:1-6.
17. Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. J Med Genet 1979;16:140-6.
18. Bellus GA, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995;56:368-73.
19. Mahomed NN, Spellmann M, Goldberg MJ. Functional health status of adults with achondroplasia. Am J Med Genet 1998;78:30-5.
20. Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI Jr. Medical complications of achondroplasia: a multicentre patient review. J Med Genet 1998;35:705-12.
21. Horton WA, Rotter JI, Rimoin DL, Scott CI, Hall JG. Standard growth curves for achondroplasia. J Pediatr 1978;93:435-8.
22. Horton WA. Dwarfism - an overview. Recent developments in diagnostic and genetic concepts. J Kans Med Soc 1978;79:58-61.
23. Filly RA, Golbus MS, Carey JC, Hall JG. Short-limbed dwarfism: ultrasonographic diagnosis by mensuration of fetal femoral length. Radiology 1981;138:653-6.
24. Patel MD, Filly RA. Homozygous achondroplasia: US distinction between homozygous, heterozygous, and unaffected fetuses in the second trimester. Radiology 1995;196:541-5.
25. Stanescu R, Stanescu V, Maroteaux P. Homozygous achondroplasia: morphologic and biochemical study of cartilage. Am J Med Genet 1990;37:412-21.
26. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989;45:498-506.
27. Bieber FR, Hoffman EP. Duchenne and Becker muscular dystrophies: genetics, prenatal diagnosis, and future prospects. Clin Perinatol 1990;17:845-65.
28. Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci USA 1985;82:4778-82.
29. Ray PN, Belfall B, Duff C, Logan C, Kean V, Thompson MW, et al. Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 1985;318:672-5.
30. Worton RG, Brooke MH. The X-linked muscular dystrophies. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited diseases, vol. 1. New York: McGraw-Hill, Inc; 1995. p. 419-21.
31. Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 1989;45:835-47.
32. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nat Genet 1993;3:283-91.
33. Bakker E, Van Broeckhoven C, Bonten EJ, van de Vooren MJ, Veenema H, Van Hul W, et al. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 1987;329:554-6.
34. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 1988;16:11141-56.
35. Tantravahi U, Nicholls RD, Stroh H, Ringer S, Neve RL, Kaplan L, et al. Quantitative calibration and use of DNA probes for investigating chromosome abnormalities in the Prader-Willi syndrome. Am J Med Genet 1989;33:78-87.
36. Darras BT. Molecular genetics of Duchenne and Becker muscular dystrophy. J Pediatr 1990;117:1-15.
37. Ward PA, Hejtmancik JF, Witkowski JA, Baumbach LL, Gunnell S, Speer J, et al. Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis. Am J Hum Genet 1989;44:270-81.
38. Abbs S, Roberts RG, Mathew CG, Bentley DR, Bobrow M. Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene. Genomics 1990;7:602-6.
39. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Pathol 1999;154:635-47.
40. Spence JE, Perciaccante RG, Greig GM, Willard HF, Ledbetter DH, Hejtmancik JF, et al. Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet 1988;42:217-26.
41. Cassidy SB. Prader-Willi syndrome. J Med Genet 1997;34:917-23.
42. Williams CA, Zori RT, Hendrickson J, Stalker H, Marum T, Whidden E, et al. Angelman syndrome. Curr Probl Pediatr 1995;25:216-31.
43. Williams CA, Angelman H, Clayton-Smith J, Driscoll DJ, Hendrickson JE, Knoll JH, et al. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet 1995;56:237-8.
44. Stalker HJ, Williams CA. Genetic counseling in Angelman syndrome: the challenges of multiple causes. Am J Med Genet 1998;77:54-9.
45. Purvis-Smith SG, Saville T, Manass S, Yip MY, Lam-Po-Tang PR, Duffy B, et al. Uniparental disomy 15 resulting from "correction" of an initial trisomy 15. Am J Hum Genet 1992;50:1348-50.
46. Glenn CC, Deng G, Michaelis RC, Tarleton J, Phelan MC, Surh L, et al. DNA methylation analysis with respect to prenatal diagnosis of the Angelman and Prader-Willi syndromes and imprinting. Prenat Diagn 2000;20:300-6.
47. Glenn CC, Porter KA, Jong MT, Nicholls RD, Driscoll DJ. Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet 1993;2:2001-5.
48. Reed ML, Leff SE. Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome. Nat Genet 1994;6:163-7.
49. Glenn CC, Saitoh S, Jong MT, Filbrandt MM, Surti U, Driscoll DJ, et al. Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet 1996;58:335-46.
50. Toth-Fejel S, Olson S, Gunter K, Quan F, Wolford J, Popovich BW, et al. The impact of imprinting: Prader-Willi syndrome resulting from chromosome translocation, recombination, and nondisjunction. Am J Hum Genet 1996;58:1008-16.
51. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-58.
52. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet 1996;64:196-7.
53. Chudley AE, Hagerman RJ. Fragile X syndrome. J Pediatr 1987;110:821-31.
54. Fisch GS. What is associated with the fragile X syndrome? Am J Med Genet 1993;48:112-21.
55. Reiss AL, Kazazian HH Jr, Krebs CM, McAughan A, Boehm CD, Abrams MT, et al. Frequency and stability of the fragile X premutation. Hum Mol Genet 1994;3:393-8.
56. Oostra BA, Halley DJ. Complex behavior of simple repeats: the fragile X syndrome. Pediatr Res 1995;38:629-37.
57. Bianchi DW, Lo YM. Fetomaternal cellular and plasma DNA trafficking: the Yin and the Yang. Ann NY Acad Sci 2001;945:119-31.
58. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002;22:609-15.
59. Pertl B, Bianchi DW. Fetal DNA in maternal plasma: emerging clinical applications. Obstet Gynecol 2001;98:483-90.
60. Handyside AH, Lesko JG, Tarin JJ, Winston RM, Hughes MR. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med 1992;327:905-9.
61. Kristjansson K, Chong SS, Van den Veyver IB, Subramanian S, Snabes MC, Hughes MR. Preimplantation single cell analyses of dystrophin gene deletions using whole genome amplification. Nat Genet 1994;6:19-23.
62. Snabes MC, Chong SS, Subramanian SB, Kristjansson K, DiSepio D, Hughes MR. Preimplantation single-cell analysis of multiple genetic loci by whole-genome amplification. Proc Natl Acad Sci USA 1994;91:6181-5.
63. Soussis I, Harper JC, Handyside AH, Winston RM. Obstetric outcome of pregnancies resulting from embryos biopsied for pre-implantation diagnosis of inherited disease. Br J Obstet Gynaecol 1996;103:784-8.
64. Cronin MT, Fucini RV, Kim SM, Masino RS, Wespi RM, Miyada CG. Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays. Hum Mutat 1996;7:244-55.
65. Lappin S, Cahlik J, Gold B. Robot printing of reverse dot blot arrays for human mutation detection. J Mol Diagn 2001;3:178-88.